Evaluation of the subjective and reinforcing effects of diphenhydramine, levetiracetam, and valproic acid

Journal of Psychopharmacology

Volumn 25, Issue 6, 2011, Pages 763-773

  Feltner, Douglas E ^a   Haig, George ^b  

^a PFIZER INC   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

diazepam abuse potential; diphenhydramine; Levetiracetam; valproic acid

Indexed keywords

ALCOHOL; DIAZEPAM; DIPHENHYDRAMINE; ETIRACETAM; PENTOBARBITAL; PLACEBO; SEDATIVE AGENT; VALPROIC ACID;

ADDICTION RESEARCH CENTER INVENTORY; ADULT; ANTICHOLINERGIC SYNDROME; ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG EFFECT; DRUG EFFECTS QUESTIONNAIRE; DRUG INFORMATION; DRUG WITHDRAWAL; DYSPHORIA; FEMALE; HUMAN; HUMAN EXPERIMENT; LABORATORY TEST; LEARNING; MALE; MOOD; NEXT DAY QUESTIONNAIRE; NORMAL HUMAN; OBSERVER RATED QUESTIONNAIRE; PHARMACOLOGIC CLASS QUESTIONNAIRE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEDATION; SINGLE DRUG DOSE; SUBJECTIVE EFFECTS QUESTIONNAIRE; VOLUNTEER;

ADOLESCENT; ADULT; AFFECT; BLOOD PRESSURE; DIPHENHYDRAMINE; FEMALE; HEART RATE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; PENTOBARBITAL; PIRACETAM; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES; REINFORCEMENT (PSYCHOLOGY); RESPIRATORY RATE; SELF REPORT; VALPROIC ACID;

EID: 79960492193     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881109359095     Document Type: Article

References (31)

1. Betts T, Waegemans T, Crawford P. A multicenter, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy. Seizure. 2000 ; 9: 80-87 (Pubitemid 30209795)
2. Buschke H, Fuld PA. Evaluating retention, storage and retrieval in disordered memory and learning. Neurology. 1974 ; 11: 1019-1025
3. Busto U, Simpkins J, Sellers EM, Sisson B, Segal R. Objective determination of benzodiazepine use and abuse in alcoholics. Br J Addict. 1983 ; 78: 429-435 (Pubitemid 14141584)
4. Comer SD, Ashworth JB, Foltin RW, Johanson CE, Zacny JP, Walsh SL. The role of human drug self-administration procedures in the development of medications. Drug Alcohol Depend. 2008 ; 96: 1-15
5. De Smedt T, Raedt R, Vonk K, Boon P. Levetiracetam: the profile of a novel anticonvulsant drug-part 1: preclinical data. CNS Drug Rev. 1997 ; 13: 43-56
6. Dew B, Elifson K, Dozier M. Social and environmental factors and their influence on drug use vulnerability and resiliency in rural populations. J Rural Health. 2007 ; 23 (Suppl). 16-21
7. de Wit H, Griffiths RR. Testing the abuse liability of anxiolytics and hypnotics in humans. Drug Alcohol Depend. 1991 ; 28: 83-111
8. Evans SM, Griffiths RR, de Wit H. Preference for diazepam but not buspirone in moderate drinkers. Psychopharmacology. 1996 ; 123: 154-163 (Pubitemid 26041913)
9. Fletcher A, Bonell C, Hargreaves J. School effects on young people's drug use: a systematic review of intervention and observational studies. J Adolesc Health. 2008 ; 42: 209-220
10. Griffiths RR, Johnson MW. Relative abuse liability of hypnotic drugs: a conceptual framework and algorithm for differentiating among compounds. J Clin Psychiatry. 2005 ; 66 (Suppl 9). 31-41 (Pubitemid 43011561)
11. Griffiths RR, Rush CR, Puhala KA. Validation of the multiple-choice procedure for investigating drug reinforcement in humans. Exp Clin Psychopharmacol. 1996 ; 4: 97-106 (Pubitemid 26077300)
12. Jasinski DR. An evaluation of the abuse potential of modafinil using methylphenidate as a reference. J Psychopharmacol. 2000 ; 14: 53-60 (Pubitemid 30156539)
13. Lezak M, Howieson D, Loring D, Hanny J, Fischer J. Neuropsychological assessment. 2004 ;:
14. Loscher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog Neurobiol. 1999 ; 58: 31-59 (Pubitemid 29166878)
15. Martijena I, Lacerra C, Bustos SG, Molina VA. Chronic benzodiazepine administration facilitates the subsequent development of ethanol dependence. Brain Res. 2001 ; 891: 236-246 (Pubitemid 32115513)
16. Martin WR, Sloan JW, Sapira JD, Jasinski DR. Physiological, subjective and behavioral effects of d-amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther. 1971 ; 12: 245-258
17. Martinez JM, Russell JM, Hirschfeld JMA. Tolerability of oral loading dose of divalproex sodium in the treatment of acute mania. Depress Anxiety. 1998 ; 7: 83-86 (Pubitemid 28235119)
18. Mumford GK, Silverman K, Griffiths RR. Reinforcing, subjective, and performance effects of lorazepam and diphenhydramine in humans. Exp Clin Psychopharmacol. 1996 ; 4: 421-430 (Pubitemid 26414543)
19. Depakene (valproic acid). 61 st edn Montvale, NJ: Thompson PDR ; 2007: 417-422.
20. Preston KL, Jasinski DR. Abuse liability studies of opioid agonist-antagonists in humans. Drug Alcohol Depend. 1991 ; 28: 49-82
21. Preston KL, Guarino JJ, Kirk T, Griffiths RR. Evaluation of the abuse potential of methocarbamol. J Pharmacol Exp Ther. 1989 ; 248: 1146-1157 (Pubitemid 19100768)
22. Preston KL, Wolf B, Guarino JJ, Griffiths RR. Subjective and behavioral effects of diphrenhydramine, lorazepam, and methocarbamol: Evaluation of abuse liability. J Pharmacol Exp Ther. 1992 ; 262: 707-720
23. Radtke RA. Pharmacokinetics of levetiracetam. Epilepsia. 2001 ; 42 (Suppl 4). 24-37
24. Rush CR, Frey JM, Griffiths RR. Zaleplon and triazolam in humans: acute behavioral effects and abuse potential. Psychopharmacology. 1999 ; 145: 39-51 (Pubitemid 29339761)
25. Scherbaum N, Specka M. Factors influencing the course of opiate addiction. Int J Methods Psychiatr Res. 2008 ; 17 (1 Suppl). S39 - S44
26. Sinha S, Naritoku DK. Intravenous valproate is well-tolerated in unstable patients with status epilepticus. Neurology. 2000 ; 55: 722-724
27. Thomas A, Nallur DG, Jones N, Deslandes PN. Diphenhydramine abuse and detoxification: a brief review and case report. J Psychopharmacol. 2008 ;:
28. Venkataraman V, Wheless JW. Safety of rapid intravenous infusion of valproate loading doses in epilepsy patients. Epilepsy Res. 1999 ; 35: 147-153 (Pubitemid 29243046)
29. Wertz JM, Sayette MA. A review of the effects of perceived drug use opportunity of self-reported urge. Exp Clin Psychopharmacol. 2001 ; 9: 3-13 (Pubitemid 32852206)
30. Williams RSB, Cheng L, Mudge AW, Harwood AJ. A common mechanism of action for three mood-stabilizing drugs. Nature. 2002 ; 417: 292-295 (Pubitemid 34534711)
31. Woods JH, Katz JL, Winger G. Abuse liability of benzodiazepines. Pharmacol Rev. 1987 ; 39: 251-419